Primus In News
How to ensure sustainability and wider stakeholder acceptability in NLEM revisions
07-12-2022
Nilaya Varma, CEO and Managing Director, Primus Partners shares his thoughts on the 4th revision of the National List of Essential Medicines, in particular releasing frequent revisions to the list as well as providing greater financial incentives to pharma companies.
Explore Related Insights
- The Need For Global Giants To Stay Invested In India’s Manufacturing Ecosystem: R&D, Exports, Livelihoods And Beyond: From The Lens Of Automotive Industry
- Responsible gaming and shared responsibility: Online gaming industry in India challenges
- Moving the Needle | September 2024
- Moving the Needle | November 2024
